On the cover of Journal for Clinical Studies SMS-oncology illustrates the landscape of early-phase oncology studies in the Netherlands
The Netherlands has been a natural favourite for conducting clinical research, with the Dutch healthcare system ranking among the best in Europe, the high level of education of investigators, large number of key opinion leaders, high quality Standard of Care (SOC) as well as the specialist centres in place that enable collection of reliable data. As an oncology dedicated contract research organisation, specialising in early-phase oncology drug development, SMS-oncology’s expertise mirrors the contemporary landscape for clinical cancer drug research within its home base in the Netherlands.
As a nation with a long trading history, the Netherlands is famous for being a country of entrepreneurial mentality. As the government and school education encourages start-ups and innovation, nearly 12% of the Dutch working population is self-employed.